+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Soft Mist Inhaler"

Respiratory Inhalers Market Report and Forecast 2024-2032 - Product Thumbnail Image

Respiratory Inhalers Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
From
US Inhalation Systems Market Forecast up to 2024 - Product Thumbnail Image

US Inhalation Systems Market Forecast up to 2024

  • Report
  • January 2019
  • 98 Pages
  • United States
From
Loading Indicator

The Soft Mist Inhaler (SMI) is a type of inhaler used to deliver medication to the lungs. It is a breath-activated device that produces a fine mist of medication, which is then inhaled by the patient. SMIs are used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. They are also used to deliver medications for other conditions, such as allergies and COPD. SMIs are becoming increasingly popular due to their convenience and ease of use. They are also more cost-effective than other inhalers and nebulisers, making them a viable option for many patients. SMIs are also more discreet than other inhalers, making them a preferred choice for those who need to take their medication in public. The SMI market is highly competitive, with a number of companies offering a range of products. These include GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. Other companies in the market include 3M, Philips, and Teva Pharmaceuticals. Show Less Read more